MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Efficacy of Ventral Intermediate Nucleus Deep Brain Stimulation for Head Tremors in Essential Tremor: A Single-Center Retrospective Analysis

S. Anis, M. Munyeshyaka, J. Hsu, N. Mandava, C. Piccinin, R. Rammo, S. Nagel, H. Fernandez (Cleveland, USA)

Meeting: 2025 International Congress

Keywords: Deep brain stimulation (DBS), Essential tremor(ET), Ventralis intermedius nucleus(VIM)

Category: Tremor

Objective: To evaluate the efficacy of ventral intermediate nucleus (VIM) deep brain stimulation (DBS) in treating head tremors in patients with essential tremor (ET) and identify potential associated factors.

Background: While VIM DBS is well established for limb tremor reduction in ET, its effect on head tremor remains less defined.

Method: We conducted a retrospective chart review of patients with ET who underwent unilateral or bilateral VIM DBS (October 2019 to July 2024). Patients had a preoperative head tremor score of ≥ 1 on the Fahn-Tolosa-Marin Clinical Rating Scale. Demographic and clinical data were collected to assess treatment efficacy. The Wilcoxon Signed-Rank test assessed changes in head tremor severity. Exact logistic regression evaluated associations between baseline tremor severity, age, disease duration, and gender with achieving a one-point reduction. Model performance was assessed using the area under the receiver operating characteristic curve (AUC). Equivalence testing and a linear mixed-effects model assessed sustained improvement, using a predefined equivalence margin of ± 0.5 points.

Results: A total of 54 patients met the inclusion criteria. The median age was 72 years (IQR: 68-75), with a median disease duration of 22 years (IQR: 12-38), and 92.6% with bilateral implant. The median preoperative head tremor severity score (resting + postural) was 2 (IQR: 1-3), which significantly improved to 0 (IQR: 0-1) postoperatively (p<0.001). The average reduction in head tremor score was 1.6 points (95% CI: -1.95, -1.30). Overall, 87% of patients demonstrated a positive response, and equivalence testing confirmed sustained improvement over a median follow-up of 14 months (IQR: 8-25 months).

Conclusion: VIM DBS demonstrates significant efficacy in reducing head tremors in ET, with the majority of patients experiencing sustained improvement.

To cite this abstract in AMA style:

S. Anis, M. Munyeshyaka, J. Hsu, N. Mandava, C. Piccinin, R. Rammo, S. Nagel, H. Fernandez. Efficacy of Ventral Intermediate Nucleus Deep Brain Stimulation for Head Tremors in Essential Tremor: A Single-Center Retrospective Analysis [abstract]. Mov Disord. 2025; 40 (suppl 1). https://www.mdsabstracts.org/abstract/efficacy-of-ventral-intermediate-nucleus-deep-brain-stimulation-for-head-tremors-in-essential-tremor-a-single-center-retrospective-analysis/. Accessed October 5, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2025 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/efficacy-of-ventral-intermediate-nucleus-deep-brain-stimulation-for-head-tremors-in-essential-tremor-a-single-center-retrospective-analysis/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley